Business model of Heidi

Category	Details
How Heidi Started	Founded in 2019 by Dr. Thomas Kelly (vascular surgical resident), Waleed Mussa, and Yu Liu. Initially launched as Oscer focusing on clinical training tools, then rebranded to Heidi Health in 2021, pivoting to AI medical scribe technology with products launching in early 2024.
Present Condition	Serves 10,000+ doctors across Australia, UK, and US. Valued at $465 million post Series B ($65M). Has returned 18+ million hours to healthcare providers in 18 months. Backed by Point72, Salesforce Ventures, Airtree Ventures.
Future of Company & Industry	AI medical scribe market experiencing explosive growth as physician burnout reaches crisis levels. Heidi positioned for global expansion targeting NHS and US healthcare systems. Industry trend: EHR integration becoming standard (Epic, Oracle partnerships with AI scribes).
Opportunities for Young Entrepreneurs	Healthcare AI automation addressing clinical workflow inefficiencies. Specialty-specific documentation tools. Integration platforms connecting AI scribes with existing healthcare IT infrastructure. Regional/language-specific solutions for underserved markets.
Market Share of Heidi	Emerging player in fragmented market dominated by Microsoft’s Nuance DAX and Abridge. Competitors include Suki, Ambience Healthcare ($1.25B valuation), Nabla, Deepscribe. Heidi’s strength: international presence beyond US-focused competitors.
MOAT (Competitive Advantage)	Medical knowledge graph built from millions of patient encounters. Founder-led team with clinical expertise (Dr. Kelly as practicing surgeon). Multi-market regulatory compliance (Australia, UK, US). Natural language processing trained on diverse clinical specialties.
How Heidi Makes Money	Subscription-based SaaS model charging per clinician per month (estimated $50-150 range based on competitor pricing). Revenue from healthcare organizations, private practices, and individual physicians. Potential enterprise contracts with hospital systems.